BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding BioCardia, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 22 | 10 | −12 |
| SharesConverted for a 1-for-15 split | 129.7K | 86.6K | −43.1K (−33.2%) |
| Value | $790.8K | $227.8K | −$563.0K (−71.2%) |
New holders (1)
Institutions that held BioCardia, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 44,557 | $132.3K | 0.00% |
Sold out (13)
Institutions that held BioCardia, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| CM Management, LLC | 700,000 | $284.9K |
| Two Sigma Securities, LLC | 111,079 | $45.2K |
| Family Management Corp | 77,500 | $31.5K |
| BlackRock Inc. | 45,891 | $18.7K |
| Brown Advisory Inc | 33,085 | $13.5K |
| Commonwealth Equity Services, LLC | 30,000 | $12.0K |
| State Street Corp | 21,000 | $8.55K |
| Northern Trust Corp | 19,226 | $7.83K |
| Wedbush Securities Inc | 15,000 | $6.00K |
| Virtu Financial LLC | 14,053 | $6.00K |
| Octavia Wealth Advisors, LLC | 14,238 | $5.79K |
| Simplex Trading, LLC | 7,207 | $2.00K |
| Wells Fargo & Company | 109 | $44 |